ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-5.3%
5Y CAGR-26.0%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-5.3%/yr
vs -14.1%/yr prior
5Y CAGR
-26.0%/yr
Recent acceleration
Acceleration
+8.8pp
Accelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.22 | +33.0% |
| 2024 | 3.17 | -55.0% |
| 2023 | 7.06 | +41.9% |
| 2022 | 4.98 | -35.7% |
| 2021 | 7.74 | -59.4% |
| 2020 | 19.04 | +2.5% |
| 2019 | 18.57 | +103.1% |
| 2018 | 9.15 | -69.1% |
| 2017 | 29.56 | -84.7% |
| 2016 | 192.80 | - |